hotspot
Previous article:
The cancer drug shortage isn’t new — and neither are the solutions
Next article: FDA does about
Next article: FDA does about
focus
focus
-
A Q&A with Aletha Maybank, AMA’s chief health equity officer
2025-10-02 12:23 -
Readout Newsletter: Ironwood, Pfizer, FogPharma updates
2025-10-02 12:16 -
Scientists unlock the key to scar
2025-10-02 12:03 -
Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline
2025-10-02 12:03 -
Pfizer highlights cancer drugs it thinks could reignite investor interest
2025-10-02 11:27 -
ALS groups 'won't be played again' by the FDA, drug sponsors
2025-10-02 10:44